Small volume bone marrow aspirates with high progenitor cell concentrations maximize cell therapy dose manufacture and substantially reduce donor hemoglobin loss. - Epah J; Spohn G; Preiß K; Müller MM; Dörr J; Bauer R; Daqiq-Mirdad S; Schwäble J; Bernas SN; Schmidt AH; Seifried E; Schäfer R (BMC medicine, 2023)